MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.

Gene therapies represent a revolutionary approach, aiming to correct the underlying genetic mutations responsible for certain ...

The US government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains, raising concerns among experts.

White House National Economic Council Director Kevin Hassett insisted Thursday that Donald Trump “always wins,” even after ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S.

By combining the MERFISH imaging technique with expanded microscopy, scientists have opened up a new way to study bacteria at ...

“While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger unwanted immune ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been ...